| Literature DB >> 31795282 |
Abstract
Free radical pathways play a major role in the degradation of protein pharmaceuticals. Inspired by biochemical reactions carried out by thiyl radicals in various enzymatic processes, this review focuses on the role of thiyl radicals in pharmaceutical protein degradation through hydrogen atom transfer, electron transfer, and addition reactions. These processes can lead to the epimerization of amino acids, as well as the formation of various cleavage products and cross-links. Examples are presented for human insulin, human and mouse growth hormone, and monoclonal antibodies.Entities:
Keywords: cross-link; fragmentation; oxidation; protein stability; therapeutic proteins; thiyl radicals
Mesh:
Substances:
Year: 2019 PMID: 31795282 PMCID: PMC6930596 DOI: 10.3390/molecules24234357
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Cartoon displaying the disulfide bonds (in red) of insulin.
Scheme 1Covalent H/D-exchange mediated by thiyl radicals, representatively shown for an αC–H bond.
Scheme 2Formation of dithiohemiacetal subsequent to the disproportionation of a thiyl radical pair.
Figure 2Cartoon displaying the disulfide bonds (in red) of human growth hormone.
Scheme 3Thiyl radical mediated conversion of Cys to Gly (glycyl).
Scheme 4Formation of vinylether from Ser.
Scheme 5Formation of vinylether form Tyr.